Decreased immunoexpression of survivin could be a potential marker in human non-alcoholic fatty liver disease progression?
Article first published online: 26 NOV 2010
© 2010 John Wiley & Sons A/S
Volume 31, Issue 3, pages 377–385, March 2011
How to Cite
Stefano, J. T., de Oliveira, C. P. M. S., Corrêa-Giannella, M. L., Soares, I. C., Kubrusly, M. S., Bellodi-Privato, M., de Mello, E. S., de Lima, V. M. R., Carrilho, F. J. and Alves, V. A. F. (2011), Decreased immunoexpression of survivin could be a potential marker in human non-alcoholic fatty liver disease progression?. Liver International, 31: 377–385. doi: 10.1111/j.1478-3231.2010.02370.x
- Issue published online: 1 FEB 2011
- Article first published online: 26 NOV 2010
- Received 28 May 2010, Accepted 16 October 2010
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- If your institution does not currently subscribe to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.